Mazen M. Dimachkie

Mazen M. Dimachkie, M.D., FAAN, FANA, is a professor, executive vice chairman, vice chairman for research programs and director of the neuromuscular division in the Department of Neurology at the University of Kansas Medical Center. Committed to excellence in neuromuscular care, research and education, Dr. Dimachkie provides exceptional and personalized diagnostic evaluation and clinical care services, and strongly believes in empowering patients with reliable educational materials. He also offers to neuromuscular patients direct access to cutting-edge research and clinical trials.

After receiving his medical degree from the American University of Beirut in Lebanon and two years of internal medicine residency at Saint Agnes Hospital in Baltimore, Dr. Dimachkie completed his residency in neurology and fellowship training in electromyography and neuromuscular disease at the University of Texas Health Science Center at Houston, where he also served on the neurology faculty before joining KU Medical Center in 2007. In addition to being certified by the American Board of Psychiatry and Neurology (ABPN) in neurology, clinical neurophysiology and neuromuscular medicine, Dr. Dimachkie holds a certificate in clinical neuromuscular pathology from the United Council for Neurologic Subspecialties (UCNS). He is a fellow of the American Academy of Neurology and the American Neurological Association.

A prolific researcher, Dr. Dimachkie leads one of the largest neuromuscular clinical trial units in North America. He leads and contributes to a variety of federally funded neuromuscular research studies and actively participates in national and international industry-sponsored studies. Dr. Dimachkie is the author or co-author of more than 500 abstracts, articles and book chapters. He is a frequently invited lecturer on inflammatory muscle disorders, Pompe disease, myasthenia gravis, LEMS, ALS, neuropathies and other neuromuscular disorders. Dr. Dimachkie is a member of the Myasthenia Gravis Foundation of America Medical Scientific Advisory Board (MSAB) and has served on The Myositis Association MSAB. He serves as a coordinator for the International Myositis Assessment and Clinical Studies Group (IMACS).